Published 12:25 IST, December 4th 2020
US expert Fauci apologises for doubting UK's vaccine approval, cites 'misunderstanding'
Top American infectious disease expert Dr Fauci, on December 3, apologized for casting doubt on the rigour of British regulators who approved Pfizer vaccine.
Advertisement
Top American infectious disease expert Dr Anthony Fauci, on December 3, apologised for casting doubt on rigour of British regulators who approved Pfizer Inc. vaccine against COVID-19 and said that he had “faith” in quality of ir work. On December 2, UK became first country in world to approve Pfizer/BioNTech vaccine against coronavirus. approval has t only given hope to millions of Britons who are battling strict restrictions but also to country’s ecomy who has been pushed to brink by pandemic.
Advertisement
Fauci apologises for doubting UK
Speaking to Fox News on vember 3, American health expert had accused British regulators of t scrutinizing data carefully eugh and having waved vaccine through. However later in day, speaking to BBC, Fauci asserted that his earlier comments had come out wrong. Calling it as a “misunderstanding” , he admitted that he was “sorry” for confusion caused. Adding furr, he said that he did have “great faith” in both scientific community and regulatory community of UK.
Advertisement
Clarifying furr, he said that he did t mean to imply that re had been any sloppiness in British regulatory process, although it came out that way. Dr Fauci said that point he was trying to make was that had it been America, same speed and same way of regulation would t have sufficed owing to widespread vaccine skepticism.
UK regulators defend approval
Pfizer/BioNTech is fastest ever vaccine to go from concept to reality, taking only 10 months to follow same developmental steps that rmally span a decade. UK has defended its approval process and said jab is safe and effective. Dr June Raine, head of UK medicines regulator, on December 2 said that " corners had been cut" in vetting jab. Medicines and Healthcare Products Regulatory ncy (MHRA) reviewed preliminary data on vaccine trials dating back to June.
Advertisement
Advertisement
12:26 IST, December 4th 2020